Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
Share with a colleague
Pharmaceutical Executive Europe  E-News
 
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecutive
 
Survey
We asked 40 pharma leaders, what area do you think will see increased regulatory attention and enforcement in 2013?
Foreign APIs 30%

GMP inspections

18%
Counterfeit medicines 30%
Social media and digital marketing 9%
Other 13%

Talk to us:
jupton@advanstar.com

Advertise with us:
Dtaylor-higgins@advanstar.com

22 January, 2013
In this Issue
Pharma Still Doesn't Get Patient Groups
A recent survey of patient groups worldwide revealed that perceptions of the pharmaceutical industry soured in the past year, mainly due to issues of access, pricing, patient safety and transparency. It seems Big Pharma is still struggling to understand what "patient-centeredness" truly means ...Read more
Why Don't Those Damn Pharma Marketers 'Do' Digital?
After years of thanklessly trying to preach and teach the virtues of digital channels, Sven Awege realizes that he might not have been looking at the problem through the right prism ... Read more
Can Regulatory Professionals Make Business Leaders
Attracting skilled regulatory staff is crucial to a company's success. But do such individuals have ahead for business? Susan Macdonald looks at how regulatory professionals can become business leaders ... Read more
Marketing: 'One Size Fits All' Fits No-one
We are now in the age of making every marketing pound/dollar/euro count with more and more sophisticated approaches. But creating 'targeted lists' isn't always the answer, writes Patrick Homer ... Read more
Read the New, Revamped Pharm Exec Global Digest
In the January 2013 issue: What Now for Greece? — Brazil's War on AIDS — The African Markets Pharma Can't Ignore — and Global Safety and Harmonization Efforts 2013 ... Read more
Also in this issue
Will 'Robust' Pipeline Yield More Drugs?
The Puzzle Master: An Interview with EMA's Guido Rasi
Crowd Sourcing for Patient Recruitment: The Time Has Come